Does Massachusetts Medicaid cover Wegovy and Zepbound in 2026?
No, not since Jul 3, 2026. As of Oct 23, 2026, Massachusetts Medicaid no longer covers GLP-1 drugs for obesity alone.
Coverage ended in 2026 Checked Oct 23, 2026 Coverage ended Jul 3, 2026
Coverage of GLP-1 drugs for obesity alone under Massachusetts’s fee-for-service Medicaid drug rules, as the state publishes them. The plan decides each request.
Massachusetts’s rule
In plain words
Coverage ended in 2026
MassHealth no longer covers drugs used to treat obesity or overweight, effective July 3, 2026. Other approved indications continue with prior authorization.
Source
MassHealth Pharmacy Facts #271 (corrected), Mar 12, 2026 (opens in new tab). Checked Oct 23, 2026.
Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization. Social Security Act §1927(d)(1)(A) and (d)(2)(A), 42 U.S.C. 1396r-8(d) (opens in new tab).
What changed
- Jul 3, 2026: MassHealth stopped covering drugs used to treat obesity or overweight; other approved uses continue with prior authorization. MassHealth Pharmacy Facts #271 (corrected), Mar 12, 2026 (opens in new tab)
Next steps
Where to go from here
Neighbouring states
Questions this page answers
Does Massachusetts Medicaid cover Wegovy and Zepbound for weight loss?
No, not since Jul 3, 2026. As of Oct 23, 2026, Massachusetts Medicaid no longer covers GLP-1 drugs for obesity alone. MassHealth no longer covers drugs used to treat obesity or overweight, effective July 3, 2026. Other approved indications continue with prior authorization.
Has Massachusetts’s rule changed recently?
Jul 3, 2026: MassHealth stopped covering drugs used to treat obesity or overweight; other approved uses continue with prior authorization.
Where does this information come from?
From MassHealth Pharmacy Facts #271 (corrected), Mar 12, 2026, read on Oct 23, 2026. Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization.
Kymata Health reads each state’s own Medicaid documents. See every state on the map.